Literature DB >> 2155379

Molecular forms in human serum of enzymes synthesizing DNA precursors and DNA.

A R Karlström1, M Neumüller, J S Gronowitz, C F Källander.   

Abstract

Both thymidine kinase (TK) and DNA polymerase (DNAp) are present in measurable amounts in human serum. Even though the use of TK as a clinical marker is rapidly increasing there has been no attempt to characterize the serum TK in a wider extent, i.e.; with respect to Mw or other biochemical parameters. Therefore sera with high TK or DNAp activities derived from patients with cytomegalovirus (CMV) infection, B12-deficiency and leukaemia were fractionated by gel exclusion chromatography. The TK activity eluted as two peaks, one major TK activity with an apparent molecular weight (Mw) or 730 kD and one minor TK activity corresponding to a Mw of 58 kD. The amount of TK activity at 58 kD varied between 7 and 23% of total activity, depending on the serum fractionated. The DNAp activity in sera from patients with malignant disease and B12 deficiency eluted as a single peak corresponding to a Mw of 240 kD. A DNAp with a different Mw (greater than 1000 kD) was recovered from 1 of 3 investigated immunosuppressed patients with CMV infection. A similar pattern of enzyme forms was observed when sera were separated by glycerol gradient centrifugation. The effect of high salt and various reaction solution components on the enzymes were studied. The only condition found that affected the molecular forms of TK was the state of reduction. Incubation of sera with high concentrations of dithioerythritol (DTE) (400 mM) prior to separation transferred all serum TK to the 58 kD form, it also converted most of the serum DNAp from the 240 kD form to a smaller form (56 kD) without affecting the total recovery of enzymatic activity. The reaction product from both TK forms was exclusively monophosphate and none of the TK forms could efficiently utilize cytidine triphosphate as phosphate donor. The substrate kinetics of the small serum TK fraction was identical with those of an enzyme with similar size purified from proliferating HeLa cells, indicating that both serum TK activities are forms of TK 1, the proliferation associated cellular isozyme.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155379     DOI: 10.1007/BF00220716

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  A method for determining the sedimentation behavior of enzymes: application to protein mixtures.

Authors:  R G MARTIN; B N AMES
Journal:  J Biol Chem       Date:  1961-05       Impact factor: 5.157

2.  Detection and characteristics of DNA polymerase activity in serum from patients with malignant, viral, or B12-deficiency disease.

Authors:  M Neumuller; C F Källander; J S Gronowitz
Journal:  Enzyme       Date:  1989

3.  Acyclic guanosine analogs as substrates for varicella-zoster virus thymidine kinase.

Authors:  A R Karlström; C F Källander; G Abele; A Larsson
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

4.  DNA polymerase-alpha: enzymology, function, fidelity, and mutagenesis.

Authors:  L A Loeb; P K Liu; M Fry
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1986

5.  Assignment of the gene for galactokinase to human chromosome 17 and its regional localisation to band q21-22.

Authors:  S M Elsevier; R S Kucherlapati; E A Nichols; R P Creagan; R E Giles; F H Ruddle; K Willecke; J K McDougall
Journal:  Nature       Date:  1974-10-18       Impact factor: 49.962

Review 6.  Viral-associated and induced enzymes.

Authors:  S Kit
Journal:  Pharmacol Ther B       Date:  1979

7.  An optimized thymidylate kinase assay, based on enzymatically synthesized 5-[125I]iododeoxyuridine monophosphate and its application to an immunological study of herpes simplex virus thymidine-thymidylate kinases.

Authors:  A R Karlström; J S Gronowitz
Journal:  Anal Biochem       Date:  1987-05-01       Impact factor: 3.365

8.  Evaluation of serum deoxythymidine kinase as a marker in multiple myeloma.

Authors:  B Simonsson; C F Källander; G Brenning; A Killander; A Ahre; J S Gronowitz
Journal:  Br J Haematol       Date:  1985-10       Impact factor: 6.998

9.  Alternative metabolic fates of thymine nucleotides in human cells.

Authors:  M R Taheri; R G Wickremasinghe; A V Hoffbrand
Journal:  Biochem J       Date:  1981-02-15       Impact factor: 3.857

10.  Human thymidine kinase. Purification and properties of the cytosolic enzyme of placenta.

Authors:  T E Gan; J L Brumley; M B Van der Weyden
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

View more
  6 in total

1.  Breast and prostate cancer patients differ significantly in their serum Thymidine kinase 1 (TK1) specific activities compared with those hematological malignancies and blood donors: implications of using serum TK1 as a biomarker.

Authors:  Kiran Kumar Jagarlamudi; Lars Olof Hansson; Staffan Eriksson
Journal:  BMC Cancer       Date:  2015-02-18       Impact factor: 4.430

2.  Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.

Authors:  Kiran Kumar Jagarlamudi; Sara Westberg; Henrik Rönnberg; Staffan Eriksson
Journal:  BMC Vet Res       Date:  2014-10-08       Impact factor: 2.741

3.  Novel monoclonal antibodies against thymidine kinase 1 and their potential use for the immunotargeting of lung, breast and colon cancer cells.

Authors:  Edwin J Velazquez; Taylor D Brindley; Gajendra Shrestha; Eliza E Bitter; Jordan D Cress; Michelle H Townsend; Bradford K Berges; Richard A Robison; K Scott Weber; Kim L O'Neill
Journal:  Cancer Cell Int       Date:  2020-04-16       Impact factor: 5.722

4.  Analytical and clinical characterization of an optimized dual monoclonal sandwich ELISA for the quantification of thymidine kinase 1 (TK1) protein in human blood samples.

Authors:  K K Jagarlamudi; Swinkels L; Zupan M; Osredkar J; Venge P; Eriksson S
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

5.  Preferent Diaphragmatic Involvement in TK2 Deficiency: An Autopsy Case Study.

Authors:  Sara Laine-Menéndez; Cristina Domínguez-González; Alberto Blázquez; Aitor Delmiro; Inés García-Consuegra; Miguel Fernández-de la Torre; Aurelio Hernández-Laín; Javier Sayas; Miguel Ángel Martín; María Morán
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

6.  Quaternary structures of recombinant, cellular, and serum forms of thymidine kinase 1 from dogs and humans.

Authors:  Sharif Hanan; Kiran Kumar Jagarlamudi; Wang Liya; He Ellen; Eriksson Staffan
Journal:  BMC Biochem       Date:  2012-06-28       Impact factor: 4.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.